• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估2'-脱氧-2'-氟反义寡核苷酸用于杜氏肌营养不良症外显子跳跃的效果。

Evaluation of 2'-Deoxy-2'-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy.

作者信息

Jirka Silvana M G, Tanganyika-de Winter Christa L, Boertje-van der Meulen Joke W, van Putten Maaike, Hiller Monika, Vermue Rick, de Visser Peter C, Aartsma-Rus Annemieke

机构信息

Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.

BioMarin, Leiden, The Netherlands.

出版信息

Mol Ther Nucleic Acids. 2015 Dec 1;4(12):e265. doi: 10.1038/mtna.2015.39.

DOI:10.1038/mtna.2015.39
PMID:26623937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5014533/
Abstract

Duchenne muscular dystrophy (DMD) is a severe muscle wasting disorder typically caused by frame-shifting mutations in the DMD gene. Restoration of the reading frame would allow the production of a shorter but partly functional dystrophin protein as seen in Becker muscular dystrophy patients. This can be achieved with antisense oligonucleotides (AONs) that induce skipping of specific exons during pre-mRNA splicing. Different chemical modifications have been developed to improve AON properties. The 2'-deoxy-2'-fluoro (2F) RNA modification is attractive for exon skipping due to its ability to recruit ILF2/3 proteins to the 2F/pre-mRNA duplex, which resulted in enhanced exon skipping in spinal muscular atrophy models. In this study, we examined the effect of two different 2'-substituted AONs (2'-F phosphorothioate (2FPS) and 2'-O-Me phosphorothioate (2OMePS)) on exon skipping in DMD cell and animal models. In human cell cultures, 2FPS AONs showed higher exon skipping levels than their isosequential 2OMePS counterparts. Interestingly, in the mdx mouse model, 2FPS was less efficient than 2OMePS and suggested safety issues as evidenced by increased spleen size and weight loss. Our results do not support a clinical application for 2FPS AON.

摘要

杜氏肌营养不良症(DMD)是一种严重的肌肉萎缩性疾病,通常由DMD基因中的移码突变引起。恢复阅读框将允许产生较短但部分功能正常的抗肌萎缩蛋白,就像在贝克型肌营养不良症患者中看到的那样。这可以通过反义寡核苷酸(AON)来实现,反义寡核苷酸可在mRNA前体剪接过程中诱导特定外显子的跳跃。人们已经开发出不同的化学修饰来改善AON的特性。2'-脱氧-2'-氟(2F)RNA修饰因其能够将ILF2/3蛋白募集到2F/mRNA前体双链体上而对外显子跳跃具有吸引力,这导致脊髓性肌萎缩模型中外显子跳跃增强。在本研究中,我们研究了两种不同的2'-取代AON(2'-氟硫代磷酸酯(2FPS)和2'-O-甲基硫代磷酸酯(2OMePS))对DMD细胞和动物模型中外显子跳跃的影响。在人类细胞培养中,2FPS AON比其等序列的2OMePS对应物表现出更高的外显子跳跃水平。有趣的是,在mdx小鼠模型中,2FPS的效率低于2OMePS,并且脾脏大小增加和体重减轻证明存在安全性问题。我们的结果不支持2FPS AON的临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/5014533/2abaa0c8d677/mtna201539f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/5014533/a627cc960381/mtna201539f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/5014533/02bdd5ce70b2/mtna201539f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/5014533/54d968ff2edd/mtna201539f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/5014533/2abaa0c8d677/mtna201539f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/5014533/a627cc960381/mtna201539f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/5014533/02bdd5ce70b2/mtna201539f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/5014533/54d968ff2edd/mtna201539f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/292d/5014533/2abaa0c8d677/mtna201539f4.jpg

相似文献

1
Evaluation of 2'-Deoxy-2'-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy.评估2'-脱氧-2'-氟反义寡核苷酸用于杜氏肌营养不良症外显子跳跃的效果。
Mol Ther Nucleic Acids. 2015 Dec 1;4(12):e265. doi: 10.1038/mtna.2015.39.
2
In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.2'-O-甲基硫代磷酸酯和吗啉代反义寡核苷酸用于杜氏肌营养不良症外显子跳跃的体内比较。
J Gene Med. 2009 Mar;11(3):257-66. doi: 10.1002/jgm.1288.
3
Nonclinical Exon Skipping Studies with 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn-/- Mice Inspired by Clinical Trial Results.基于临床试验结果的 2'-O-甲基硫代磷酸酯反义寡核苷酸在 mdx 和 mdx-utrn-/- 小鼠中非临床外显子跳跃研究。
Nucleic Acid Ther. 2019 Apr;29(2):92-103. doi: 10.1089/nat.2018.0759. Epub 2019 Jan 23.
4
Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular Dystrophy.用于杜氏肌营养不良症的下一代外显子 51 跳跃反义寡核苷酸。
Nucleic Acid Ther. 2023 Jun;33(3):193-208. doi: 10.1089/nat.2022.0063. Epub 2023 Apr 10.
5
Designing Effective Antisense Oligonucleotides for Exon Skipping.设计用于外显子跳跃的有效反义寡核苷酸
Methods Mol Biol. 2018;1687:143-155. doi: 10.1007/978-1-4939-7374-3_10.
6
Exon 51 Skipping Quantification by Digital Droplet PCR in del52hDMD/mdx Mice.通过数字液滴PCR对del52hDMD/mdx小鼠中外显子51跳跃进行定量分析
Methods Mol Biol. 2018;1828:249-262. doi: 10.1007/978-1-4939-8651-4_15.
7
Cyclic Peptides to Improve Delivery and Exon Skipping of Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy.环状肽可改善肌营养不良症小鼠模型中反义寡核苷酸的传递和外显子跳跃。
Mol Ther. 2018 Jan 3;26(1):132-147. doi: 10.1016/j.ymthe.2017.10.004. Epub 2017 Oct 12.
8
Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells.用于肌肉细胞中靶向DMD基因第46外显子跳跃的反义寡核苷酸类似物的比较分析
Gene Ther. 2004 Sep;11(18):1391-8. doi: 10.1038/sj.gt.3302313.
9
Challenges of Assessing Exon 53 Skipping of the Human Transcript with Locked Nucleic Acid-Modified Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy.用锁核酸修饰的反义寡核苷酸评估杜氏肌营养不良症小鼠模型中人转录本外显子 53 跳跃的挑战。
Nucleic Acid Ther. 2023 Dec;33(6):348-360. doi: 10.1089/nat.2023.0038.
10
Development of antisense-mediated exon skipping as a treatment for duchenne muscular dystrophy.反义介导的外显子跳跃技术作为杜氏肌营养不良症治疗方法的发展。
Ann N Y Acad Sci. 2009 Sep;1175:71-9. doi: 10.1111/j.1749-6632.2009.04973.x.

引用本文的文献

1
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases.剪接调节反义寡核苷酸作为遗传性代谢疾病的治疗方法。
BioDrugs. 2024 Mar;38(2):177-203. doi: 10.1007/s40259-024-00644-7. Epub 2024 Jan 22.
2
Evaluation of Chemically Modified Nucleic Acid Analogues for Splice Switching Application.用于剪接转换应用的化学修饰核酸类似物的评估。
ACS Omega. 2023 Dec 11;8(51):48650-48661. doi: 10.1021/acsomega.3c07618. eCollection 2023 Dec 26.
3
Targeted tissue delivery of RNA therapeutics using antibody-oligonucleotide conjugates (AOCs).

本文引用的文献

1
Dystrophin Analysis in Clinical Trials.临床试验中的肌营养不良蛋白分析
J Neuromuscul Dis. 2014;1(1):41-53.
2
2'-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF.2'-氟修饰的硫代磷酸酯寡核苷酸可导致P54nrb和PSF快速降解。
Nucleic Acids Res. 2015 May 19;43(9):4569-78. doi: 10.1093/nar/gkv298. Epub 2015 Apr 8.
3
Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: results of a double-blind randomized clinical trial.
利用抗体-寡核苷酸缀合物(AOCs)实现 RNA 治疗药物的靶向组织递送。
Nucleic Acids Res. 2023 Jul 7;51(12):5901-5910. doi: 10.1093/nar/gkad415.
4
A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review.杜氏肌营养不良症基因靶向治疗策略十年进展:系统综述
Front Bioeng Biotechnol. 2022 Mar 23;10:833833. doi: 10.3389/fbioe.2022.833833. eCollection 2022.
5
Control of backbone chemistry and chirality boost oligonucleotide splice switching activity.控制主链化学和手性可增强寡核苷酸剪接切换活性。
Nucleic Acids Res. 2022 Jun 10;50(10):5443-5466. doi: 10.1093/nar/gkac018.
6
From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies.从反义RNA到RNA修饰:基于RNA技术的治疗潜力。
Biomedicines. 2021 May 14;9(5):550. doi: 10.3390/biomedicines9050550.
7
Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant suppressing factor 9 RNA biogenesis leading to hemophilia B.导致乙型血友病的非编码变异抑制因子 9 RNA 生成的病理机制和反义寡核苷酸介导的挽救作用。
PLoS Genet. 2020 Apr 8;16(4):e1008690. doi: 10.1371/journal.pgen.1008690. eCollection 2020 Apr.
8
Using a State-of-the-Art Toolbox to Evaluate Molecular and Functional Readouts of Antisense Oligonucleotide-Induced Exon Skipping in Mice.利用最先进的工具包评估反义寡核苷酸诱导的小鼠外显子跳跃的分子和功能读数。
Nucleic Acid Ther. 2020 Feb;30(1):50-65. doi: 10.1089/nat.2019.0824. Epub 2019 Dec 10.
9
Efficient Epidermal Growth Factor Receptor Targeting Oligonucleotide as a Potential Molecule for Targeted Cancer Therapy.高效表皮生长因子受体靶向寡核苷酸作为一种潜在的靶向癌症治疗分子。
Int J Mol Sci. 2019 Sep 22;20(19):4700. doi: 10.3390/ijms20194700.
10
Systematic evaluation of 2'-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro.体外系统评价 2'-氟修饰嵌合反义寡核苷酸介导的外显子跳跃。
Sci Rep. 2019 Apr 15;9(1):6078. doi: 10.1038/s41598-019-42523-0.
杜氏肌营养不良症非卧床受试者单次给予 drisapersen 的药代动力学和安全性:一项双盲随机临床试验结果。
Neuromuscul Disord. 2014 Jan;24(1):16-24. doi: 10.1016/j.nmd.2013.09.004. Epub 2013 Sep 11.
4
A chemical view of oligonucleotides for exon skipping and related drug applications.用于外显子跳跃及相关药物应用的寡核苷酸的化学视角。
Nucleic Acid Ther. 2014 Feb;24(1):37-47. doi: 10.1089/nat.2013.0454. Epub 2013 Oct 30.
5
Eteplirsen for the treatment of Duchenne muscular dystrophy.依替膦酸酯治疗杜氏肌营养不良症。
Ann Neurol. 2013 Nov;74(5):637-47. doi: 10.1002/ana.23982. Epub 2013 Sep 10.
6
Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK).新生儿足跟血筛查杜氏肌营养不良症:威尔士(英国) 21 年经验。
Eur J Hum Genet. 2013 Oct;21(10):1049-53. doi: 10.1038/ejhg.2012.301. Epub 2013 Jan 23.
7
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing.合成寡核苷酸募集 ILF2/3 到 RNA 转录本以调节剪接。
Nat Chem Biol. 2012 Apr 15;8(6):555-61. doi: 10.1038/nchembio.939.
8
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.系统注射磷酰胺吗啉寡聚物治疗杜氏肌营养不良症患者的外显子跳跃和肌营养不良蛋白修复:一项开放标签、2 期、剂量递增研究。
Lancet. 2011 Aug 13;378(9791):595-605. doi: 10.1016/S0140-6736(11)60756-3. Epub 2011 Jul 23.
9
Systemic administration of PRO051 in Duchenne's muscular dystrophy.普罗 051 用于杜氏肌营养不良的系统给药。
N Engl J Med. 2011 Apr 21;364(16):1513-22. doi: 10.1056/NEJMoa1011367. Epub 2011 Mar 23.
10
Antisense-mediated modulation of splicing: therapeutic implications for Duchenne muscular dystrophy.反义寡核苷酸介导的剪接调控:杜氏肌营养不良症的治疗意义。
RNA Biol. 2010 Jul-Aug;7(4):453-61. doi: 10.4161/rna.7.4.12264. Epub 2010 Jul 1.